Thus, antigens capable of stimulating the development of a Th1 response, as represented by production of high levels of IFN-γ in mice naive or chronically infected with Leishmania, as opposite conditions, could be considered promising candidates for use as a vaccine against leishmaniasis. Here, IFNG is linked to leishmaniasis.